The Challenge of CMC Regulatory Compliance for Biopharmaceuticals by John Geigert.
An effective CMC regulatory compliance strategy for biologics and biopharmaceuticals can seem like a mystery. Through means of this 2nd edition, this no longer needs to occur. A great deal of thanks goes to two regulatory authorities – the United States Food and Drug Administration (FDA) and the E...
Full description
Saved in: